Thomas Jefferson University Hospital
 
DEPARTMENT OF DERMATOLOGY AND CUTANEOUS BIOLOGY

Scleroderma Center

Division of Connective Tissue Diseases

Thanks to everyone who participated in our October 4, 2008 Patient education Workshop jointly hosted by The Scleroderma Center and the Scleroderma Foundation to celebrate the 35th Anniversary of the Scleroderma Center and the 10th Anniversary of the Scleroderma Foundation Program.

Sergio A. Jimenez, M.D.
Director

Francesco Del Galdo, M.D., Ph.D.
Associate Director

Phone: 215-955-6680 

Jefferson's Scleroderma Center offers an exceptional level of clinical focus on this prevalent and debilitating disease, as well as on Raynaud's disease and related disorders. Staffed by physicians who are world leaders in their field, the center treats a large patient group with both established medical therapies and experimental treatments. It coordinates the expert evaluation and management of various organ systems that may be affected by scleroderma, as well as the performance of numerous clinical and basic science research projects aimed at discovering the cause of the disease and effective treatments. Jefferson’s Scleroderma Center participates in national and international clinical trials of the latest therapies for the disease, including bone marrow transplantation.

What is Scleroderma (Systemic Sclerosis)?
Current Research Projects

Congratulations to our Director, Sergio A. Jimenez, M.D., who will receive the very prestigious honor of being named an ACR Master at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Francisco on October 25, 2008 for his distinguished career as a researcher and clinician in the molecular biology of rheumatological diseases.

Philadelphia Top Hospitals

Jefferson's Scleroderma Center has been recognized as a Center of Excellence (2008) and Top Hospital for the "Best Care in Philadelphia" (2003) by Philadelphia Magazine. According to the magazine, “The patient roster reads like a United Nations roll call” and the Center’s director, “international expert Sergio Jimenez, probably knows more about the disease than anyone in the world…”